Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Luca Calani, Daniele Del Rio, Maria Luisa Callegari, Lorenzo Morelli & Furio Brighenti. (2012) Updated bioavailability and 48 h excretion profile of flavan-3-ols from green tea in humans. International Journal of Food Sciences and Nutrition 63:5, pages 513-521.
Read now
Read now
Michal Šiller, Pavel Anzenbacher, Eva Anzenbacherová, Karel Doležal & Miroslav Strnad. (2011) In vitro interaction of a novel neutrophil growth factor with human liver microsomal cytochromes P450 and the contribution of UDP-glucuronosyltransferases to its metabolism. Xenobiotica 41:11, pages 934-944.
Read now
Read now
Petra Jančová, Michal Šiller, Eva Anzenbacherová, Vladimír Křen, Pavel Anzenbacher & Vilím Šimánek. (2011) Evidence for differences in regioselective and stereoselective glucuronidation of silybin diastereomers from milk thistle (Silybum marianum) by human UDP-glucuronosyltransferases. Xenobiotica 41:9, pages 743-751.
Read now
Read now
Articles from other publishers (32)
Lukasz Dobrek. (2023) A Synopsis of Current Theories on Drug-Induced Nephrotoxicity. Life 13:2, pages 325.
Crossref
Crossref
Mingyue Zhu, Zhenhao Tian, Lingling Jin, Xiaokui Huo, Chao Wang, Jingnan Cui, Yan Tian, Xiangge Tian & Lei Feng. (2021) A highly selective fluorescent probe for real-time imaging of UDP-glucuronosyltransferase 1A8 in living cells and tissues. Frontiers of Chemical Science and Engineering 16:1, pages 103-111.
Crossref
Crossref
Yazun Jarrar & Su-Jun Lee. (2021) The Functionality of UDP-Glucuronosyltransferase Genetic Variants and their Association with Drug Responses and Human Diseases. Journal of Personalized Medicine 11:6, pages 554.
Crossref
Crossref
Herana Kamal SeneviratneJoseph TillotsonJulie M. LadeLinda-Gail BekkerSue LiSubash PathakJessica JustmanNyaradzo MgodiShobha SwaminathanNirupama SistaJennifer FarriorPaul RichardsonCraig W. HendrixNamandje N. Bumpus. (2021) Metabolism of Long-Acting Rilpivirine After Intramuscular Injection: HIV Prevention Trials Network Study 076 (HPTN 076). AIDS Research and Human Retroviruses 37:3, pages 173-183.
Crossref
Crossref
Ye Liu, Michael K. Ng & Stephen Wu. (2018) Multi-domain Networks Association for Biological Data Using Block Signed Graph Clustering. IEEE/ACM Transactions on Computational Biology and Bioinformatics, pages 1-1.
Crossref
Crossref
K.M. Knights. 2018. Comprehensive Toxicology. Comprehensive Toxicology
517
540
.
Huma Mehboob, Imtiaz Mahmood Tahir, Tahir Iqbal, Naheed Akhter, Naveed Munir & Muhammad Riaz. 2017. Genetic Polymorphisms. Genetic Polymorphisms.
JO Miners, X Yang, KM Knights & L Zhang. (2017) The Role of the Kidney in Drug Elimination: Transport, Metabolism, and the Impact of Kidney Disease on Drug Clearance. Clinical Pharmacology & Therapeutics 102:3, pages 436-449.
Crossref
Crossref
John O. Miners, Nuy Chau, Andrew Rowland, Kushari Burns, Ross A. McKinnon, Peter I. Mackenzie, Geoffrey T. Tucker, Kathleen M. Knights & Ganessan Kichenadasse. (2017) Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia. Biochemical Pharmacology 129, pages 85-95.
Crossref
Crossref
Peter I. Mackenzie, Andrew A. Somogyi & John O. Miners. (2017) Advances in drug metabolism and pharmacogenetics research in Australia. Pharmacological Research 116, pages 7-19.
Crossref
Crossref
Min Xu, Peipei Dong, Xiangge Tian, Chao Wang, Xiaokui Huo, Baojing Zhang, Lijun Wu, Sa Deng & Xiaochi Ma. (2016) Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction. Pharmacological Research 110, pages 139-150.
Crossref
Crossref
Kathleen M. Knights, Shane M. Spencer, John K. Fallon, Nuy Chau, Philip C. Smith & John O. Miners. (2016)
Scaling factors for the
in vitro
-
in vivo
extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearance
. British Journal of Clinical Pharmacology 81:6, pages 1153-1164.
Crossref
Crossref
Zofia Mazerska, Anna Mróz, Monika Pawłowska & Ewa Augustin. (2016) The role of glucuronidation in drug resistance. Pharmacology & Therapeutics 159, pages 35-55.
Crossref
Crossref
J. Matthew Hutzler & Michael A. Zientek. 2015. New Horizons in Predictive Drug Metabolism and Pharmacokinetics. New Horizons in Predictive Drug Metabolism and Pharmacokinetics
79
130
.
Attarat Pattanawongsa, Nuy Chau, Andrew Rowland & John O. Miners. (2015) Inhibition of Human UDP-Glucuronosyltransferase Enzymes by Canagliflozin and Dapagliflozin: Implications for Drug-Drug Interactions. Drug Metabolism and Disposition 43:10, pages 1468-1476.
Crossref
Crossref
Guillaume Margaillan, Michèle Rouleau, John K. Fallon, Patrick Caron, Lyne Villeneuve, Véronique Turcotte, Philip C. Smith, Melanie S. Joy & Chantal Guillemette. (2015) Quantitative Profiling of Human Renal UDP-glucuronosyltransferases and Glucuronidation Activity: A Comparison of Normal and Tumoral Kidney Tissues. Drug Metabolism and Disposition 43:4, pages 611-619.
Crossref
Crossref
Xiangge Tian, Sicheng Liang, Chao Wang, Baojian Wu, Guangbo Ge, Sa Deng, Kexin Liu, Ling Yang & Xiaochi Ma. (2014) Regioselective Glucuronidation of Andrographolide and Its Major Derivatives: Metabolite Identification, Isozyme Contribution, and Species Differences. The AAPS Journal 17:1, pages 156-166.
Crossref
Crossref
Xiang-Ge Tian, Chao Wang, Guang-Bo Ge, Jing Ning, Chun-Zhi Ai, James Y. Hong, Yong-Xv Cai, Xiao-Kui Huo, Jie Hou, Ke-Xin Liu, Hong-Zhi Sun & Xiao-Chi Ma. (2015) A highly selective probe for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human microsomes: isoform specificity, kinetic characterization, and applications. RSC Advances 5:8, pages 5924-5927.
Crossref
Crossref
Cynthia Van der Hauwaert, Grégoire Savary, David Buob, Xavier Leroy, Sébastien Aubert, Vincent Flamand, Marie-Flore Hennino, Michaël Perrais, Jean-Marc Lo-Guidice, Franck Broly, Christelle Cauffiez & François Glowacki. (2014) Expression profiles of genes involved in xenobiotic metabolism and disposition in human renal tissues and renal cell models. Toxicology and Applied Pharmacology 279:3, pages 409-418.
Crossref
Crossref
Laurent Grosse, Anne-Sophie Campeau, Sarah Caron, Frédéric-Alexandre Morin, Kim Meunier, Jocelyn Trottier, Patrick Caron, Mélanie Verreault & Olivier Barbier. (2013) Enantiomer Selective Glucuronidation of the Non-Steroidal Pure Anti-Androgen Bicalutamide by Human Liver and Kidney: Role of the Human UDP-Glucuronosyltransferase (UGT)1A9 Enzyme. Basic & Clinical Pharmacology & Toxicology 113:2, pages 92-102.
Crossref
Crossref
Eva Choong, Irena Loryan, Marja Lindqvist, Åsa Nordling, Samira el Bouazzaoui, Ron H. van Schaik, Inger Johansson, Jan Jakobsson & Magnus Ingelman-Sundberg. (2013) Sex Difference in Formation of Propofol Metabolites: A Replication Study. Basic & Clinical Pharmacology & Toxicology 113:2, pages 126-131.
Crossref
Crossref
Andrew Rowland, John O. Miners & Peter I. Mackenzie. (2013) The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification. The International Journal of Biochemistry & Cell Biology 45:6, pages 1121-1132.
Crossref
Crossref
H.A.M. Mutsaers, M.J.G. Wilmer, D. Reijnders, J. Jansen, P.H.H. van den Broek, M. Forkink, E. Schepers, G. Glorieux, R. Vanholder, L.P. van den Heuvel, J.G. Hoenderop & R. Masereeuw. (2013) Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1832:1, pages 142-150.
Crossref
Crossref
Alexander V. LyubimovShalu Jhajra, Ninad Ramesh Varkhede, Deepak Suresh Ahire, Bukke Vidyasagar Naik, Bhagwat Prasad, Jyoti Paliwal & Saranjit Singh. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
99
.
Shingo Oda, Miki Nakajima, Masahiko Hatakeyama, Tatsuki Fukami & Tsuyoshi Yokoi. (2012) Preparation of a Specific Monoclonal Antibody against Human UDP-Glucuronosyltransferase (UGT) 1A9 and Evaluation of UGT1A9 Protein Levels in Human Tissues. Drug Metabolism and Disposition 40:8, pages 1620-1627.
Crossref
Crossref
Vimal Kumar, Andrew C. Johnson, Norihide Nakada, Naoyuki Yamashita & Hiroaki Tanaka. (2012) De-conjugation behavior of conjugated estrogens in the raw sewage, activated sludge and river water. Journal of Hazardous Materials 227-228, pages 49-54.
Crossref
Crossref
Liping Ma, Jianguo Sun, Ying Peng, Rong Zhang, Feng Shao, Xiaoling Hu, Jianping Zhu, Xiaojin Wang, Xuefang Cheng, Yinci Zhu, Ping Wan, Dong Feng, Hui Wu & Guangji Wang. (2012) Glucuronidation of Edaravone by Human Liver and Kidney Microsomes: Biphasic Kinetics and Identification of UGT1A9 as the Major UDP-Glucuronosyltransferase Isoform. Drug Metabolism and Disposition 40:4, pages 734-741.
Crossref
Crossref
Alexander V. LyubimovDeepak K. Dalvie & Cho‐Ming Loi. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
36
.
Yongchuan Gu, Malcolm D. Tingle & William R. Wilson. (2011) Glucuronidation of Anticancer Prodrug PR-104A: Species Differences, Identification of Human UDP-Glucuronosyltransferases, and Implications for Therapy. Journal of Pharmacology and Experimental Therapeutics 337:3, pages 692-702.
Crossref
Crossref
Jiping Wang, Allan M Evans, Kathleen M Knights & John O Miners. (2011) Differential disposition of intra-renal generated and preformed glucuronides: studies with 4-methylumbelliferone and 4-methylumbelliferyl glucuronide in the filtering and nonfiltering isolated perfused rat kidney. Journal of Pharmacy and Pharmacology 63:4, pages 507-514.
Crossref
Crossref
Judith Bellemare, M?lanie Rouleau, Mario Harvey, Ion Popa, Georges Pelletier, Bernard T?tu & Chantal Guillemette. (2011) Immunohistochemical expression of conjugating UGT1A-derived isoforms in normal and tumoral drug-metabolizing tissues in humans. The Journal of Pathology 223:3, pages 425-435.
Crossref
Crossref
Melanie S. Joy, Tammy Boyette, Yichun Hu, Jinzhao Wang, Mary La, Susan L. Hogan, Paul W. Stewart, Ronald J. Falk, Mary Anne Dooley & Philip C. Smith. (2010) Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis. European Journal of Clinical Pharmacology 66:11, pages 1119-1130.
Crossref
Crossref